![Celltrion Inc Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/krx/068270.png?tr=w-200)
Celltrion Inc
KRX:068270
![Celltrion Inc Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/krx/068270.png)
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Realty Income Corp
NYSE:O
|
Real Estate
|
US |
![]() |
Walt Disney Co
NYSE:DIS
|
Media
|
US |
![]() |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
131 800
231 500
|
Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Realty Income Corp
NYSE:O
|
US |
![]() |
Walt Disney Co
NYSE:DIS
|
US |
![]() |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/krx/068270.png)
Intrinsic Value
Celltrion, Inc. engages in the development, manufacture and distribution of pharmaceuticals. [ Read More ]
The intrinsic value of one
Celltrion Inc
stock under the Base Case scenario is
168 219.18
KRW.
Compared to the current market price of 200 000 KRW,
Celltrion Inc
is
Overvalued by 16%.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/krx/068270.png?tr=w-200)
Valuation Backtest
Celltrion Inc
Run backtest to discover the historical profit from buying and selling
Celltrion Inc
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Celltrion Inc
Current Assets | 5T |
Cash & Short-Term Investments | 731.8B |
Receivables | 975.7B |
Other Current Assets | 3.3T |
Non-Current Assets | 14.9T |
Long-Term Investments | 135.4B |
PP&E | 1.2T |
Intangibles | 13.3T |
Other Non-Current Assets | 222.1B |
Current Liabilities | 2.5T |
Accounts Payable | 50.9B |
Accrued Liabilities | 205.7B |
Short-Term Debt | 1.6T |
Other Current Liabilities | 606.4B |
Non-Current Liabilities | 466.3B |
Long-Term Debt | 107.1B |
Other Non-Current Liabilities | 359.2B |
Earnings Waterfall
Celltrion Inc
Revenue
|
2.3T
KRW
|
Cost of Revenue
|
-1.2T
KRW
|
Gross Profit
|
1.1T
KRW
|
Operating Expenses
|
-615.1B
KRW
|
Operating Income
|
479.3B
KRW
|
Other Expenses
|
-86.5B
KRW
|
Net Income
|
392.8B
KRW
|
Free Cash Flow Analysis
Celltrion Inc
KRW | |
Free Cash Flow | KRW |
Profitability Score
Profitability Due Diligence
Celltrion Inc's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/krx/068270.png)
Score
Celltrion Inc's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Celltrion Inc's solvency score is 71/100. The higher the solvency score, the more solvent the company is.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/krx/068270.png)
Score
Celltrion Inc's solvency score is 71/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Celltrion Inc
According to Wall Street analysts, the average 1-year price target for
Celltrion Inc
is 246 402.86 KRW
with a low forecast of 161 600 KRW and a high forecast of 315 000 KRW.
Price Appreciation
Price
Celltrion Inc
Average Annual Return | 11.25% |
Standard Deviation of Annual Returns | 60.27% |
Max Drawdown | -64% |
Market Capitalization | 41.4T KRW |
Shares Outstanding | 207 534 000 |
Percentage of Shares Shorted |
N/A
|
Company Profile
![Celltrion Inc Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/krx/068270.png?tr=w-200)
![Celltrion Inc Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/krx/068270.png?tr=w-200)
Country
Industry
Market Cap
Dividend Yield
Description
Celltrion, Inc. engages in the development, manufacture and distribution of pharmaceuticals. The company is headquartered in Incheon, Incheon. The company went IPO on 2005-07-19. The firm operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The firm's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The firm sells its products in domestic and overseas markets such as Europe and the United States.
Contact
IPO
Employees
Officers
The intrinsic value of one
Celltrion Inc
stock under the Base Case scenario is
168 219.18
KRW.
Compared to the current market price of 200 000 KRW,
Celltrion Inc
is
Overvalued by 16%.